Valsartan

Name: Valsartan | 137862-53-4
Brand: US-CATO
SKU: S57C4X-1057_5_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57C4X-1057_5_MG

Vendor: US-CATO

Product Information

Product Name

Valsartan

Brand Name

US-CATO

Product Number

C4X-1057

CAS

137862-53-4

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

60846

IUPAC Name

(2S)-3-methyl-2-pentanoyl-4-2-(2H-tetrazol-5-yl)phenylphenylmethylaminobutanoic acid

InChI Key

ACWBQPMHZXGDFX-QFIPXVFZSA-N

SMILES

CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C@@H(C(C)C)C(=O)O

References Data Source From Pubchem

The 70 year Odyssey of exercise training based cardiac rehabilitation with respect to medical innovations in heart failure

Publication Name: Heart Failure Reviews

Publication Date: 2026-03-03

DOI: 10.1007/s10741-026-10608-4

Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function

Publication Name: npj Drug Discovery

Publication Date: 2026-03-02

DOI: 10.1038/s44386-026-00038-5

[Sudden cardiac death in structural heart disease : Update on prevention]

Publication Name: Herz

Publication Date: 2026-03

DOI: 10.1007/s00059-026-05367-9

Understanding atrial failure: from diagnosis to clinical implications

Publication Name: Nature reviews. Cardiology

Publication Date: 2026-02-27

DOI: 10.1038/s41569-026-01266-y

Long-term risk of dementia with angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive patients: A 15-year follow-up using the 45 and Up Study

Publication Name: GeroScience

Publication Date: 2026-02-27

DOI: 10.1007/s11357-026-02173-3

Valsartan

Product Information

General Information

References Data Source From Pubchem

The 70 year Odyssey of exercise training based cardiac rehabilitation with respect to medical innovations in heart failure

Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function

[Sudden cardiac death in structural heart disease : Update on prevention]

Understanding atrial failure: from diagnosis to clinical implications

Long-term risk of dementia with angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive patients: A 15-year follow-up using the 45 and Up Study

Valsartan

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Valsartan

Product Information

General Information

References Data Source From Pubchem

The 70 year Odyssey of exercise training based cardiac rehabilitation with respect to medical innovations in heart failure

Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function

[Sudden cardiac death in structural heart disease : Update on prevention]

Understanding atrial failure: from diagnosis to clinical implications

Long-term risk of dementia with angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive patients: A 15-year follow-up using the 45 and Up Study

Valsartan

Related Product

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

#title#

Login

Register